Tough Questions, Straight Answers - Pharmaceutical Marketing & Promotion
In recent years, pharmaceutical marketing and promotion have been the subject of debate, with critics questioning the value of these efforts. This booklet offers a concise collection of the latest facts about pharmaceutical marketing and promotion and dispels many common misconceptions.
more
Principles for Government-Supported Health Outcomes Research on Medical Technologies and Services
PhRMA supports the development of high quality information about patients’ medical treatment options. Empowering patients and physicians with high quality information will help ensure that our health system efficiently delivers the best possible results for all patients. Research from a range of sources in the public and private sectors provides valuable information for patients and health care professionals in making treatment decisions.
Updated Principles For Conduct Of Clinical Trials And Communication Of Clinical Trial Results
The voluntary principles describe the relationship of PhRMA member companies with others involved in clinical research and set forth the rules companies follow to protect the safety of research participants wherever the companies conduct clinical trials. In the Principles, the PhRMA companies commit to the timely communication of all meaningful results of clinical trials, whether those results are positive or negative. Further, the results are always to be communicated in an objective, accurate, balanced and complete manner.
PhRMA Adopts New Marketing Code on Interactions with Health Professionals
The Executive Committee of the Pharmaceutical Research and Manufacturers of America (PhRMA) yesterday unanimously adopted a new marketing code to govern the pharmaceutical industry’s relationships with physicians and other healthcare professionals. The voluntary code took effect on July 1, 2002.
more
2004 Industry Profile
PhRMA is pleased to present the 2004 edition of the Pharmaceutical Industry Profile. 2003 was a historic year as Congress passed and President Bush signed into law the most important, pro-patient Medicare reform in the program’s 38-year history. Providing Medicare beneficiaries with insurance coverage that offers affordable access to medicines is essential to highquality and efficient care. The work done by Congress and the President in creating this benefit will make a real difference in millions of patients’ everyday lives, as 10 million seniors gain drug coverage for the first time and many millions more obtain better coverage than they had before. Better access to treatments that, for example, help avoid heart attacks and stroke or ease the suffering of depression is both good health care and good economics.
more
|
